Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66581-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- STT3A antibody
- Antibody type
- Monoclonal
- Description
- STT3A antibody (Cat. #66581-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1E2B12
- Vial size
- 20ul, 150ul
Submitted references Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer.
Analysis of Tumor Glycosylation Characteristics and Implications for Immune Checkpoint Inhibitor's Efficacy for Breast Cancer.
Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway.
Zhang D, Xie J, Sun F, Xu R, Liu W, Xu J, Huang X, Zhang G
Cancer letters 2024 May 1;589:216819
Cancer letters 2024 May 1;589:216819
Analysis of Tumor Glycosylation Characteristics and Implications for Immune Checkpoint Inhibitor's Efficacy for Breast Cancer.
Lv W, Yu H, Han M, Tan Y, Wu M, Zhang J, Wu Y, Zhang Q
Frontiers in immunology 2022;13:830158
Frontiers in immunology 2022;13:830158
Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway.
Cheng J, Xia L, Hao X, Gan F, Bai Y, Zhang C, Mao Y, Zhu Y, Pu Q, Park DW, Tavolari S, Mei J, Chen Y, Deng S, Liu L
Translational lung cancer research 2022 Jun;11(6):1089-1107
Translational lung cancer research 2022 Jun;11(6):1089-1107
No comments: Submit comment
No validations: Submit validation data